Cargando…

One-Month Outcomes of Intravitreal Anti-VEGF vs. Dexamethasone Implant in the Treatment of Diabetic Macular Edema in Vitrectomized Eyes

OBJECTIVES: To compare short-term effect of intravitreal ranibizumab with dexamethasone implant for diabetic macular edema (DME) in vitrectomized eyes. METHODS: Single-center, prospective, randomized study of vitrectomized eyes with DME. Study eyes were divided into two groups, receiving ranibizumab...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Youling, Yan, Bin, Xie, Manyun, Meng, Zhishang, Ma, Jiayue, Ma, Bosheng, Luo, Jing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9237330/ https://www.ncbi.nlm.nih.gov/pubmed/35774995 http://dx.doi.org/10.3389/fmed.2022.895220

Ejemplares similares

Comparison of Inflammatory and Angiogenic Factors in the Aqueous Humor of Vitrectomized and Non-Vitrectomized Eyes in Diabetic Macular Edema Patients
por: Liang, Youling, et al.
Publicado: (2021)

Effectiveness of Intravitreal Dexamethasone Implant Treatment for Diabetic Macular Edema in Vitrectomized Eyes
por: Özdemir, Hüseyin Baran, et al.
Publicado: (2019)

Comparison of Intravitreal Dexamethasone Implant and Ranibizumab in Vitrectomized Eyes with Diabetic Macular Edema
por: Wang, Jia-Kang, et al.
Publicado: (2021)

Evaluation of the Effect of Intravitreal Dexamethasone (Ozurdex(®)) Implant on Intraocular Pressure in Vitrectomized and Non-Vitrectomized Eyes with Macular Edema
por: Garlı, Murat, et al.
Publicado: (2021)

Comparison of the Effect of Intravitreal Dexamethasone Implant in Vitrectomized and Nonvitrectomized Eyes for the Treatment of Diabetic Macular Edema
por: Çevik, Sadık Görkem, et al.
Publicado: (2018)

Short-term Efficacy of Intravitreal Dexamethasone Implant in Vitrectomized Eyes with Recalcitrant Diabetic Macular Edema and Prior Anti-VEGF Therapy
por: Shah, Ankoor R., et al.
Publicado: (2016)

Choroidal Blood Flow After Intravitreal Ranibizumab in Vitrectomized and Non-Vitrectomized Eyes with Diabetic Macular Edema
por: Pessoa, Bernardete, et al.
Publicado: (2021)

Evaluation of Functional Outcomes and OCT-Biomarkers after Intravitreal Dexamethasone Implant for Postoperative Cystoid Macular Edema in Vitrectomized Eyes
por: Freissinger, Sigrid, et al.
Publicado: (2020)

Twelve-Month Follow-Up of Dexamethasone Implants for Macular Edema from Various Diseases in Vitrectomized and Nonvitrectomized Eyes
por: Novais, Eduardo A., et al.
Publicado: (2016)

One-Year Outcome of Aflibercept Intravitreal Injection in Vitrectomized Eyes with Diabetic Macular Edema
por: Tran, Thi Ha Chau, et al.
Publicado: (2021)

Two-Year Outcome of Aflibercept Intravitreal Injection in Vitrectomized Eyes with Diabetic Macular Edema
por: Tran, Thi Ha Chau, et al.
Publicado: (2022)

Effect of Dexamethasone Implant on Subfoveal Choroidal Thickness in Early Period in Vitrectomized Eyes with Diabetic Macular Edema
por: Altun, A., et al.
Publicado: (2021)

Intravitreal Tissue Plasminogen Activator Injection for Treatment-Resistant Diabetic Macular Edema of the Vitrectomized Eye
por: Aoki, Ren, et al.
Publicado: (2021)

Resolution of Persistent Cystoid Macular Edema due to Central Retinal Vein Occlusion in a Vitrectomized Eye following Intravitreal Implant of Dexamethasone 0.7 mg
por: Reibaldi, Michele, et al.
Publicado: (2012)

Efficacy and safety of the dexamethasone implant in vitrectomized and nonvitrectomized eyes with diabetic macular edema: A systematic review and meta-analysis
por: Yuan, Qiongzhen, et al.
Publicado: (2022)

Intravitreal Dexamethasone Implants for Refractory Macular Edema in Eyes with Noninfectious Uveitis
por: Kang, Eugene Yu-Chuan, et al.
Publicado: (2021)

Effectiveness of Intravitreal Ranibizumab in Nonvitrectomized and Vitrectomized Eyes with Diabetic Macular Edema: A Two-Year Retrospective Analysis
por: Gedar Totuk, Ozgun Melike, et al.
Publicado: (2020)

Real-world retrospective comparison of 0.19 mg fluocinolone acetonide and 0.7 mg dexamethasone intravitreal implants for the treatment of diabetic macular edema in vitrectomized eyes
por: Coelho, João, et al.
Publicado: (2019)

Commentary: Treatment of postoperative cystoid macular edema in vitrectomized eyes: An enigma
por: Kohli, Piyush, et al.
Publicado: (2023)

Comparison of the efficacy of intravitreal Anti-VEGF versus intravitreal dexamethasone implant in treatment resistant diabetic Macular Edema
por: Koc, Hakan, et al.
Publicado: (2023)

Intravitreal Brolucizumab for Neovascular Age-Related Macular Degeneration in a Vitrectomized Eye
por: Maggio, Emilia, et al.
Publicado: (2022)

Vitrectomized versus non-vitrectomized eyes in diabetic macular edema response to ranibizumab—retinal layers thickness as prognostic biomarkers
por: Pessoa, Bernardete, et al.
Publicado: (2021)

Dexamethasone intravitreal implant in the treatment of diabetic macular edema
por: Dugel, Pravin U, et al.
Publicado: (2015)

Prognostic Imaging Biomarkers in Diabetic Macular Edema Eyes Treated with Intravitreal Dexamethasone Implant
por: Costanzo, Eliana, et al.
Publicado: (2023)

Contralateral eye-to-eye comparison of intravitreal ranibizumab and a sustained-release dexamethasone intravitreal implant in recalcitrant diabetic macular edema
por: Thomas, Benjamin J, et al.
Publicado: (2016)

Differential response to intravitreal dexamethasone implant in naïve and previously treated diabetic macular edema eyes
por: Zarranz-Ventura, Javier, et al.
Publicado: (2020)

Office-based intravitreal injection of expansile gas for management of macular hole in previously vitrectomized eyes
por: Apolinario, Michael A., et al.
Publicado: (2019)

Combined Intravitreal Dexamethasone Implant And Micropulse Yellow Laser For Treatment Of Anti-VEGF Resistant Diabetic Macular Edema
por: Elhamid, Ahmed Hosni Abd
Publicado: (2017)

Intravitreal Dexamethasone Implantation in Intravitreal Bevacizumab Treatment-resistant Pseudophakic Cystoid Macular Edema
por: Altintas, Ayse Gul Kocak, et al.
Publicado: (2019)

Bilateral Intravitreal Dexamethasone Implant for Retinitis Pigmentosa-Related Macular Edema
por: Saatci, Ali Osman, et al.
Publicado: (2013)

Repeated Treatment for Macular Edema in Vein Occlusion by Intravitreal Implant of Dexamethasone
por: Matonti, Frederic, et al.
Publicado: (2012)

Letter to the editor: dexamethasone intravitreal implant in the treatment of diabetic macular edema
por: Hall, John
Publicado: (2015)

Outcomes of Intravitreal Dexamethasone Implant in the Treatment of Recalcitrant Diabetic Macular Edema
por: Akıncıoğlu, Dorukcan, et al.
Publicado: (2017)

Intravitreal Dexamethasone Implant in the Treatment of Non-Infectious Uveitic Macular Edema
por: Karti, Omer, et al.
Publicado: (2018)

Simultaneous Therapy with Intravitreal Dexamethasone Implant and Bevacizumab for the Treatment of Macular Edema
por: de ANDRADE, Felipe L., et al.
Publicado: (2016)

Treatment algorithm with dexamethasone intravitreal implant in patients with diabetic macular edema
por: Epstein, David, et al.
Publicado: (2019)

Efficacy of Intravitreal Dexamethasone Implant in Different Patterns of Diabetic Macular Edema
por: Furino, Claudio, et al.
Publicado: (2020)

Dexamethasone intravitreal implant in cystoid macular edema secondary to paclitaxel therapy
por: Burgos-Blasco, Barbara, et al.
Publicado: (2020)

Place of intravitreal dexamethasone implant in the treatment armamentarium of diabetic macular edema
por: Karti, Omer, et al.
Publicado: (2021)

Short-term Effects of Intravitreal Dexamethasone Implant on Choroidal Structure in Eyes with Refractory Diabetic Macular Edema
por: Bilici, Serdar, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vmk14uumv8733ecfuna4plg0gd